Cargando…
5. Isolated head drop: first symptom of anti-synthetase syndrome
INTRODUCTION: Head drop is an unusual clinical manifestation of myositis or neuromuscular weakness, and typically requires extensive investigation to identify the underlying pathology. Case report data are limited on this topic. CASE DESCRIPTION: A 72-year-old man with a background of extractable nu...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761427/ http://dx.doi.org/10.1093/rap/rkz030.004 |
_version_ | 1783454030713847808 |
---|---|
author | Parker, Lucy Soliotis, Fotini |
author_facet | Parker, Lucy Soliotis, Fotini |
author_sort | Parker, Lucy |
collection | PubMed |
description | INTRODUCTION: Head drop is an unusual clinical manifestation of myositis or neuromuscular weakness, and typically requires extensive investigation to identify the underlying pathology. Case report data are limited on this topic. CASE DESCRIPTION: A 72-year-old man with a background of extractable nuclear antigen (ENA) negative mixed connective tissue disease, trigeminal neuralgia, interstitial nephritis and ischaemic heart disease presented with an isolated head drop. On further prompting, he confirmed mild shortness of breath on exertion. He had sclerodactyly but no features of mechanic’s hands. Serum creatinine kinase was 1398 IU/L. Electromyography was myelopathic. Muscle biopsy taken from the neck was inconclusive. He had a strongly positive anti-nuclear antibody (ANA) test, and borderline myositis ENA panel result with borderline positive anti-EJ antibody. The myositis panel result prompted further investigation for underlying interstitial lung disease. Pulmonary function testing revealed a restrictive picture, with KCO of 82%. High resolution computed tomography showed areas of fine interstitial fibrotic change in all lobes. He was treated with a reducing course of oral prednisolone and 15mg weekly oral methotrexate with an excellent clinical response, with resolution of the head drop and normalisation of serum CK value. Repeat pulmonary function testing remains stable after 5 months. DISCUSSION: This is an unusual presentation of presumed anti-synthetase syndrome. As methotrexate had already been prescribed before the underlying lung pathology was identified with resulting excellent clinical response and stable respiratory symptoms, a multi-disciplinary decision was made to continue with this choice of disease modifying agent. The decision to use methotrexate in the presence of interstitial fibrosis is always difficult, and requires close liaison between rheumatology and respiratory colleagues. KEY LEARNING POINTS: Positive anti-synthetase antibodies should prompt further investigation for underlying interstitial lung disease. Head drop can be a first symptom of autoimmune myositis and warrants further investigation. CONFLICTS OF INTEREST: The authors have declared no conflicts of interest. |
format | Online Article Text |
id | pubmed-6761427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-67614272019-10-02 5. Isolated head drop: first symptom of anti-synthetase syndrome Parker, Lucy Soliotis, Fotini Rheumatol Adv Pract Poster Presentations INTRODUCTION: Head drop is an unusual clinical manifestation of myositis or neuromuscular weakness, and typically requires extensive investigation to identify the underlying pathology. Case report data are limited on this topic. CASE DESCRIPTION: A 72-year-old man with a background of extractable nuclear antigen (ENA) negative mixed connective tissue disease, trigeminal neuralgia, interstitial nephritis and ischaemic heart disease presented with an isolated head drop. On further prompting, he confirmed mild shortness of breath on exertion. He had sclerodactyly but no features of mechanic’s hands. Serum creatinine kinase was 1398 IU/L. Electromyography was myelopathic. Muscle biopsy taken from the neck was inconclusive. He had a strongly positive anti-nuclear antibody (ANA) test, and borderline myositis ENA panel result with borderline positive anti-EJ antibody. The myositis panel result prompted further investigation for underlying interstitial lung disease. Pulmonary function testing revealed a restrictive picture, with KCO of 82%. High resolution computed tomography showed areas of fine interstitial fibrotic change in all lobes. He was treated with a reducing course of oral prednisolone and 15mg weekly oral methotrexate with an excellent clinical response, with resolution of the head drop and normalisation of serum CK value. Repeat pulmonary function testing remains stable after 5 months. DISCUSSION: This is an unusual presentation of presumed anti-synthetase syndrome. As methotrexate had already been prescribed before the underlying lung pathology was identified with resulting excellent clinical response and stable respiratory symptoms, a multi-disciplinary decision was made to continue with this choice of disease modifying agent. The decision to use methotrexate in the presence of interstitial fibrosis is always difficult, and requires close liaison between rheumatology and respiratory colleagues. KEY LEARNING POINTS: Positive anti-synthetase antibodies should prompt further investigation for underlying interstitial lung disease. Head drop can be a first symptom of autoimmune myositis and warrants further investigation. CONFLICTS OF INTEREST: The authors have declared no conflicts of interest. Oxford University Press 2019-09-26 /pmc/articles/PMC6761427/ http://dx.doi.org/10.1093/rap/rkz030.004 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Presentations Parker, Lucy Soliotis, Fotini 5. Isolated head drop: first symptom of anti-synthetase syndrome |
title | 5. Isolated head drop: first symptom of anti-synthetase syndrome |
title_full | 5. Isolated head drop: first symptom of anti-synthetase syndrome |
title_fullStr | 5. Isolated head drop: first symptom of anti-synthetase syndrome |
title_full_unstemmed | 5. Isolated head drop: first symptom of anti-synthetase syndrome |
title_short | 5. Isolated head drop: first symptom of anti-synthetase syndrome |
title_sort | 5. isolated head drop: first symptom of anti-synthetase syndrome |
topic | Poster Presentations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761427/ http://dx.doi.org/10.1093/rap/rkz030.004 |
work_keys_str_mv | AT parkerlucy 5isolatedheaddropfirstsymptomofantisynthetasesyndrome AT soliotisfotini 5isolatedheaddropfirstsymptomofantisynthetasesyndrome |